Random measurement error in visual acuity measurement in clinical settings
- PMID: 15948786
- DOI: 10.1111/j.1600-0420.2005.00469.x
Random measurement error in visual acuity measurement in clinical settings
Abstract
Purpose: To estimate the random measurement error in visual acuity (VA) determination in the clinical environment in cataractous, pseudophakic and healthy eyes.
Methods: The VAs of patients referred for cataract surgery or consultation by ophthalmic professionals were re-examined and the VA results for distance using projector acuity charts were compared. Refractive errors were also remeasured. A total of 99 eyes (41 cataractous, 36 pseudophakic and 22 healthy eyes) were examined. The healthy comparison group consisted of hospital staff. Only one eye of each person and eyes with Snellen VAs of 0.3-1.3 (logMAR 0.52 to - 0.11) were included. The mean time interval between the first and second examinations was 45 days.
Results: The estimated standard deviation of measurement error (SDME) of repeated VA measurements of all eyes was logMAR 0.06. Eyes with the lowest VA (0.3-0.45) had the largest variability (SDME logMAR 0.09), and eyes with VA > or = 0.7 had the smallest (SDME logMAR 0.04). The variability may be partly explained by the line size progression in lower VAs, partly by the difference in the remeasurement of the refractive error. The difference in the average VA between examinations 1 and 2 (logMAR 0.15 versus 0.12) was considered to be of some interest because it indicates that some learning effect is possible.
Conclusion: Visual acuity results in clinical settings have a certain degree of inherent variability. In this series variability ranged from SDME logMAR 0.04 (eyes with good vision) to logMAR 0.09 (in the lower vision group) in the Snellen VA range of 0.3-1.3. Changes should be judged with caution, especially in cases of decreased VA.
Similar articles
-
Repeatability (test-retest variability) of refractive error measurement in clinical settings.Acta Ophthalmol Scand. 2006 Aug;84(4):532-6. doi: 10.1111/j.1600-0420.2006.00695.x. Acta Ophthalmol Scand. 2006. PMID: 16879577
-
[The influence of IOL implantation on visual acuity, contrast sensitivity and colour vision 2 and 4 months after cataract surgery].Cesk Slov Oftalmol. 2006 Apr;62(2):133-43. Cesk Slov Oftalmol. 2006. PMID: 16640052 Czech.
-
[Landolt C and snellen e acuity: differences in strabismus amblyopia?].Klin Monbl Augenheilkd. 2006 Jan;223(1):24-8. doi: 10.1055/s-2005-858613. Klin Monbl Augenheilkd. 2006. PMID: 16418930 German.
-
[Comparison of visual acuity measured using Landolt-C and ETDRS charts in healthy subjects and patients with various eye diseases].Klin Monbl Augenheilkd. 2011 Oct;228(10):864-7. doi: 10.1055/s-0031-1281758. Epub 2011 Oct 13. Klin Monbl Augenheilkd. 2011. PMID: 21997822 German.
-
Change of visual acuity recording methods in clinical studies across the years.Ophthalmologica. 2008;222(3):173-7. doi: 10.1159/000126080. Epub 2008 May 22. Ophthalmologica. 2008. PMID: 18497526 Review.
Cited by
-
HAS SNELLEN CHART LOST THE BATTLE TO ETDRS IN CATARACT SURGERY VISUAL ACUITY EVALUATION?Acta Clin Croat. 2022 Feb;60(3):441-449. doi: 10.20471/acc.2021.60.03.15. Acta Clin Croat. 2022. PMID: 35282473 Free PMC article.
-
Prospective evaluation of visual acuity assessment: a comparison of snellen versus ETDRS charts in clinical practice (An AOS Thesis).Trans Am Ophthalmol Soc. 2009 Dec;107:311-24. Trans Am Ophthalmol Soc. 2009. PMID: 20126505 Free PMC article.
-
Comparison of visual acuity in macular degeneration patients measured with snellen and early treatment diabetic retinopathy study charts.Ophthalmology. 2008 Feb;115(2):319-23. doi: 10.1016/j.ophtha.2007.05.028. Epub 2007 Aug 13. Ophthalmology. 2008. PMID: 17706288 Free PMC article.
-
Simulation of daily soft multifocal contact lenses using SimVis Gekko: from in-vitro and computational characterization to clinical validation.Sci Rep. 2024 Apr 13;14(1):8592. doi: 10.1038/s41598-024-59178-1. Sci Rep. 2024. PMID: 38615153 Free PMC article.
-
[Monitoring of AMD patients on anti-vascular endothelial growth factor (VEGF) treatment. Practical notes on functional and anatomical examination parameters from drug approval studies, specialist information and case series].Ophthalmologe. 2008 Feb;105(2):125-38, 140-2. doi: 10.1007/s00347-008-1702-6. Ophthalmologe. 2008. PMID: 18256841 Review. German.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical